Evidence map›Paper›PMID 28298477›Full record

ReviewMicrobiology and molecular biology reviews : MMBR2017

Central Role of the Trehalose Biosynthesis Pathway in the Pathogenesis of Human Fungal Infections: Opportunities and Challenges for Therapeutic Development.

Arsa Thammahong, Srisombat Puttikamonkul, John R Perfect, Richard G Brennan, Robert A Cramer

Open access · bronzeAbstract readReview
In one paragraph

Review in Microbiology and molecular biology reviews : MMBR, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 65 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
65citing papers in PubMed, 1 pooled it
6.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

65 citing papers in PubMed, 1 synthesis or guideline pooled it, 124 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Journal of medical microbiology · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Cryptococcal nutrient acquisition and pathogenesis: dining on the host.Microbiology and molecular biology reviews : MMBR · 2025
    Review
  13. Article
  14. Antifungal and anti-biofilm effects of hydrazone derivatives onJournal of enzyme inhibition and medicinal chemistry · 2024
    Article
  15. The Coexistence ofInternational journal of molecular sciences · 2024
    Article
  16. Review
  17. Structures of trehalose-6-phosphate synthase, Tps1, from the fungal pathogenProceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  18. The Enigma ofMicroorganisms · 2024
    Article
  19. Review
  20. Article

5 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 2 countries.

Arsa ThammahongDepartment of Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, USA.
Srisombat PuttikamonkulDepartment of Microbiology, Faculty of Medicine, Srinakharinwirot University, Bangkok, Thailand.
John R PerfectDivision of Infectious Diseases, Duke University Medical Center, Durham, North Carolina, USA.
Richard G BrennanDepartment of Biochemistry, Duke University School of Medicine, Durham, North Carolina, USA.
Robert A CramerDepartment of Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, USA Robert.A.Cramer.JR@dartmouth.edu.
Dartmouth College · USDuke Medical Center · USDuke University · USSrinakharinwirot University · TH

Funding

Trehalose Pathway for Antifungal Targets and InhibitorsP01AI104533 · NIAID · DUKE UNIVERSITY · PI BRENNAN, RICHARD GERALD · 2015 to 2019
$9.0M
TRANSLATIONAL RESEARCH COREP30GM106394 · NIGMS · DARTMOUTH COLLEGE · PI STANTON, BRUCE A. · 2013 to 2017
$6.1M
Pathobiology of C. neoformans in the Central Nervous SystemR01AI073896 · NIAID · DUKE UNIVERSITY · PI PERFECT, JOHN R. · 2008 to 2018
$4.4M
Evolution of Cryptococcus neoformans Strains from Patients with HIV/AIDSR01AI093257 · NIAID · DUKE UNIVERSITY · PI PERFECT, JOHN R. · 2011 to 2022
$3.8M
Hypoxia Adaptation and Fungal Virulence of Aspergillus fumigatusR01AI081838 · NIAID · MONTANA STATE UNIVERSITY - BOZEMAN · PI CRAMER, ROBERT ANDREW · 2009 to 2017
$2.9M
NIAID NIH HHS P01 AI104533NIAID NIH HHS R01 AI073896NIAID NIH HHS R01 AI081838NIAID NIH HHS R01 AI093257NIGMS NIH HHS P30 GM106394
6 · The paper itself

Abstract

Invasive fungal infections cause significant morbidity and mortality in part due to a limited antifungal drug arsenal. One therapeutic challenge faced by clinicians is the significant host toxicity associated with antifungal drugs. Another challenge is the fungistatic mechanism of action of some drugs. Consequently, the identification of fungus-specific drug targets essential for fitness

Indexed as

Biosynthetic PathwaysAntifungal AgentsAspergillus fumigatusCandida albicansCryptococcus neoformansDrug DiscoveryFungiGlucosyltransferasesHost-Pathogen InteractionsHumansInvasive Fungal InfectionsPhosphoric Monoester HydrolasesTrehaloseVirulenceVirulence FactorsAntifungal AgentsGlucosyltransferasesPhosphoric Monoester HydrolasesTrehalosetrehalose-6-phosphate synthasetrehalose-phosphataseVirulence Factorsantifungal agentsantifungal therapycarbon metabolismcell wallfungal pathogenesisfungal virulencetrehalose

Identifiers

PMID28298477
PMCPMC5485801
OpenAlexW2607230262

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.